SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Aug-23 8:01 PM View: | Inozyme Pharma, Inc. (INZY) | 01-Aug-23 | Private Purchase | 833,333 | $4.80 | $4,000,000.00 | 23% 3.66M to 4.49M | |
15-May-23 5:06 PM View: | Inozyme Pharma, Inc. (INZY) | 12-May-23 | Market Purchase | 228,702 | $6.25 | $1,429,390.00 | 3% 6.87M to 7.09M | (< 1%) |
15-May-23 5:06 PM View: | Inozyme Pharma, Inc. (INZY) | 11-May-23 | Market Purchase | 219,230 | $6.48 | $1,420,610.00 | 3% 6.65M to 6.87M | (4%) |
30-Mar-23 5:46 PM View: | Inozyme Pharma, Inc. (INZY) | 29-Mar-23 | Private Purchase | 344,592 | $4.54 | $1,563,720.00 | 12% 2.87M to 3.21M | |
29-Mar-23 7:30 PM View: | Inozyme Pharma, Inc. (INZY) | 28-Mar-23 | Purchase | 156,766 | $4.16 | $652,335.00 | 3% 5.42M to 5.58M | |
29-Mar-23 7:30 PM View: | Inozyme Pharma, Inc. (INZY) | 27-Mar-23 | Private Purchase | 51,074 | $3.70 | $188,729.00 | < 1% 5.37M to 5.42M | |
20-Apr-22 4:05 PM View: | Inozyme Pharma, Inc. (INZY) | 19-Apr-22 | Private Purchase | 1,070,000 | $3.69 | $3,948,300.00 | 67% 1.59M to 2.66M | |
04-Aug-21 5:52 PM View: | Rallybio Corp (RLYB) | 02-Aug-21 | Private Purchase | 576,923 | $13.00 | $7,500,000.00 | 34% 1.69M to 2.27M | |
04-Aug-21 5:52 PM View: | Rallybio Corp (RLYB) | 28-Jul-21 | Acquisition (other) | 1,694,390 | -- | -- | 100% 0 to 1.69M | |
10-Feb-21 7:22 PM View: | Vaxcyte, Inc. (PCVX) | 10-Feb-21 | Market Sale (Planned) | 78,158 | $26.53 | $2,073,660.00 | (5%) 1.48M to 1.41M | 17% |
10-Feb-21 7:22 PM View: | Vaxcyte, Inc. (PCVX) | 09-Feb-21 | Market Sale (Planned) | 220,744 | $28.19 | $6,223,690.00 | (13%) 1.7M to 1.48M | 22% |
10-Feb-21 7:22 PM View: | Vaxcyte, Inc. (PCVX) | 08-Feb-21 | Market Sale (Planned) | 79,796 | $25.79 | $2,058,120.00 | (4%) 1.78M to 1.7M | 15% |
04-Feb-21 8:51 PM View: | Vaxcyte, Inc. (PCVX) | 03-Feb-21 | Market Sale (Planned) | 2,768 | $25.06 | $69,366.10 | (< 1%) 1.79M to 1.78M | 12% |
04-Feb-21 8:51 PM View: | Vaxcyte, Inc. (PCVX) | 02-Feb-21 | Market Sale (Planned) | 14,234 | $25.13 | $357,700.00 | (< 1%) 1.8M to 1.79M | 12% |
02-Feb-21 12:17 PM View: | Vaxcyte, Inc. (PCVX) | 28-Jan-21 | Market Sale (Planned) | 2,000 | $25.07 | $50,140.00 | (< 1%) 1.8M to 1.8M | 12% |
27-Jan-21 6:02 PM View: | Vaxcyte, Inc. (PCVX) | 27-Jan-21 | Market Sale (Planned) | 2,140 | $25.30 | $54,142.00 | (< 1%) 1.81M to 1.8M | 13% |
27-Jan-21 6:02 PM View: | Vaxcyte, Inc. (PCVX) | 26-Jan-21 | Market Sale (Planned) | 18,142 | $25.30 | $458,958.00 | (< 1%) 1.82M to 1.81M | 13% |
27-Jan-21 6:02 PM View: | Vaxcyte, Inc. (PCVX) | 25-Jan-21 | Market Sale (Planned) | 34,972 | $25.81 | $902,745.00 | (2%) 1.86M to 1.82M | 15% |
22-Jan-21 6:10 PM View: | Vaxcyte, Inc. (PCVX) | 22-Jan-21 | Market Sale (Planned) | 11,383 | $25.16 | $286,396.00 | (< 1%) 1.87M to 1.86M | 13% |
22-Jan-21 6:10 PM View: | Vaxcyte, Inc. (PCVX) | 21-Jan-21 | Market Sale (Planned) | 100 | $25.11 | $2,511.00 | (< 1%) 1.87M to 1.87M | 12% |
22-Jan-21 6:10 PM View: | Vaxcyte, Inc. (PCVX) | 20-Jan-21 | Market Sale (Planned) | 19,046 | $25.35 | $482,816.00 | (1%) 1.89M to 1.87M | 13% |
19-Jan-21 9:07 PM View: | Vaxcyte, Inc. (PCVX) | 19-Jan-21 | Market Sale (Planned) | 49,516 | $25.62 | $1,268,630.00 | (3%) 1.94M to 1.89M | 14% |
19-Jan-21 9:07 PM View: | Vaxcyte, Inc. (PCVX) | 15-Jan-21 | Market Sale (Planned) | 26,677 | $25.78 | $687,846.00 | (1%) 1.97M to 1.94M | 15% |
19-Jan-21 9:07 PM View: | Vaxcyte, Inc. (PCVX) | 14-Jan-21 | Market Sale (Planned) | 14,918 | $25.88 | $386,078.00 | (< 1%) 1.98M to 1.97M | 15% |
13-Jan-21 8:39 PM View: | Vaxcyte, Inc. (PCVX) | 13-Jan-21 | Market Sale (Planned) | 29,110 | $25.95 | $755,313.00 | (1%) 2.01M to 1.98M | 15% |
13-Jan-21 8:39 PM View: | Vaxcyte, Inc. (PCVX) | 12-Jan-21 | Market Sale (Planned) | 18,567 | $26.38 | $489,871.00 | (< 1%) 2.03M to 2.01M | 17% |
13-Jan-21 8:39 PM View: | Vaxcyte, Inc. (PCVX) | 11-Jan-21 | Market Sale (Planned) | 49,666 | $26.45 | $1,313,760.00 | (2%) 2.08M to 2.03M | 17% |
08-Jan-21 5:17 PM View: | Vaxcyte, Inc. (PCVX) | 08-Jan-21 | Market Sale (Planned) | 40,612 | $26.58 | $1,079,550.00 | (2%) 2.12M to 2.08M | 17% |
08-Jan-21 5:17 PM View: | Vaxcyte, Inc. (PCVX) | 07-Jan-21 | Market Sale (Planned) | 47,580 | $28.27 | $1,344,890.00 | (2%) 2.17M to 2.12M | 22% |
08-Jan-21 5:17 PM View: | Vaxcyte, Inc. (PCVX) | 06-Jan-21 | Market Sale (Planned) | 57,420 | $29.53 | $1,695,840.00 | (3%) 2.22M to 2.17M | 26% |
28-Jul-20 6:11 PM View: | Inozyme Pharma, Inc. (INZY) | 28-Jul-20 | Conversion | 1,403,650 | -- | -- | 100% 0 to 1.4M | |
28-Jul-20 6:11 PM View: | Inozyme Pharma, Inc. (INZY) | 28-Jul-20 | Purchase | 187,500 | $16.00 | $3,000,000.00 | 13% 1.4M to 1.59M | |
16-Jun-20 7:21 PM View: | Vaxcyte, Inc. (PCVX) | 16-Jun-20 | Conversion | 2,129,970 | -- | -- | 100% 0 to 2.13M | |
16-Jun-20 7:21 PM View: | Vaxcyte, Inc. (PCVX) | 16-Jun-20 | Purchase | 93,000 | $16.00 | $1,488,000.00 | 4% 2.13M to 2.22M |